Skip to main content

Table 1 Demographic and clinicopathologic characteristics of HCC patients in the initial training set

From: Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters

Variable Name Mean ± SD/Median or % Variable Name Percentage
Survival (month) 33.8 ± 29.4/25.3 Event  
Disease free survival (month) 25.0 ± 28.9/11.7    Deceased 32.2
Age (year) 56.0 ± 12.0/56    Censored 67.8
Male 80.4% Child's grade  
Liver Function Parameters      A 97.3
   AFP [log10] (ng/mL) 2.18 ± 1.39/2.03    B 2.7
   SGPT (U/L) 61.0 ± 51.4/46 Family History of HCC 20.7
   SGOT (U/L) 64.3 ± 53.9/49 Smoking  
   BILIRUBIN (μM) 14.5 ± 11.2/12    No 55.6
   ALBUMIN (mg/mL) 40.2 ± 4.7/41    Moderate 30.5
      Heavy 13.9
Tumor Size (cm) 7.6 ± 4.1/6.5 Alcohol Drinking  
Tumor Recurrence 51.1%    No 60.5
Venous Infiltration      Moderate 23.3
   Absence 50.6%    Heavy 16.2
   Presence 49.4% No. of tumor nodule(s)  
Non-tumorous liver histology      1 76.3
   Cirrhotic 57.1%    2 6.8
   Non-cirrhotic 14.0%    3 1.5
   Chronic hepatitis 28.9%    4 1.1
pTNM Stage      5 0.4
   I 3.0%    6 0.8
   II 41.1%    Multiple >6 13.2
   IIIA 35.5% Edmondson Grade  
   IV 20.3%    Undifferentiated 1.3
AJCC Stage      Poorly Differentiated 18.3
   I 41.5%    Moderate Differentiated 59.2
   II 27.9%    Well Differentiated 21.3
   IIIA 21.9% HBsAg Status  
   IIIB 7.5%    Positive 86.1
   IV 1.1%    Negative 13.9
  1. * Drink and smoking data were self-reported: moderate drinking < = 2 drinks/per day; heavy drinking >2 drinks/per day; moderate smoking < = 1 pack/day; heavy smoking >1 pack/day